New Zealand tech firm produce virtual reality cancer immunotherapy visualisation

Wednesday 16 December 2015

New Zealand-based technology company, Genulin Interactive, have produced a cutting-edge visualisation of cancer immunotherapy.

Using the Oculus Rift virtual reality headset, and with advice from the Malaghan Institute of Medical Research, the four minute film takes researchers on a cellular journey.

The sequence is able to show the VR process of such drugs teaching the immune system's dendritic cells to recognise cancerous ones and in turn stimulate the production of T cells that are able to hunt down and destroy cancer.

“The Oculus Rift technology platform enables a new, immersive method of showing people how molecules or cells act," said Genulin Interactive's Kevin Sheehy and Chris Mather.

"We can put a person into the body to see things happening at any size, from cells forming to medicines working on receptors.

“It is likely to become part of how clinicians, patients and other people in the medical field communicate the effects of new treatments on the body. It is very exciting, and as Kiwis we are really excited to bring this to the world."

Find out more here

We promise to keep your data safe and you can unsubscribe at any time in the future. More information is in our Privacy Policy.